Targeted Medical Pharma, Inc. announced earnings results for second quarter and six months ended June 30, 2014. For the quarter, the company's total revenue of $2.2 million, a 16% improvement from $1.9 million during the three months ended June 30, 2013. Adjusted EBITDA of $0.04 million, a 103% improvement from negative $1.6 million during the three months ended June 30, 2013. Net loss was $0.42 million compared to $7.84 million for the three months ended June 30, 2013. Exclusive of income tax expense, loss before income taxes for the three months ended June 30, 2014 and 2013 was $0.36 million and $1.94 million, respectively.

For the six months, the company's total revenue was $1,397,688 compared to $8,112,242 a year ago. Net loss before interest, taxes, depreciation and amortization, and stock based compensation was $537,945 compared to $1,709,084 a year ago.